This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Taro-Docusate Capsules USP 100 mg (2014-04-25)

Starting date:
April 25, 2014
Posting date:
May 2, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-39287

Recalled products

Taro-Docusate Capsules USP 100 mg

Reason

Foreign matter identified as inert nitrile rubber was found in a capsule.

Depth of distribution

Retailers in all provinces and territories except Yukon, Northwest Territories, Nunavut, and Prince Edward Island.

Affected products

Taro-Docusate Capsules USP 100 mg

DIN, NPN, DIN-HIM
DIN 00716731
Dosage form

Capsule

Strength

100 mg

Lot or serial number
  • 230000505
  • 230000506
  • 230000507
  • 230000508
  • 230000509
  • 230000510
  • 230000491
  • 230000428
  • 230000516
Companies
Recalling Firm
Taro Pharmaceuticals Inc.
130 East Drive
Brampton
L6T 1C1
Ontario
CANADA
Marketing Authorization Holder
Taro Pharmaceuticals Inc.
130 East Drive
Brampton
L6T 1C1
Ontario
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: